drugset / Trial / NCT00464607

Prospective, Randomized, Controlled, Clinical Study on Tolerability and Efficacy of hMG-IBSA

NCT00464607 ↗

Phase 3 Completed 160 enrolled IBSA Institut Biochimique SA
RandomizedParallel-groupOpen-labelTreatment

Summary

Purpose of the study is the evaluation of the tolerability (both local and systemic) and the clinical efficacy (in terms oocytes recovered) of subcutaneously versus intramuscularly administered Merional® (IBSA, Lugano - CH) in patients undergoing controlled ovarian hyperstimulation (COH) in an ART programme (IVF).

Timeline

Start
2001-12
Primary completion
—
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject hMG-IBSA Unknown — Subcutaneous

Indications